Literature DB >> 30325408

Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus.

Kim B Pedersen1, Casey F Pulliam1, Aarshvi Patel1, Fabio Del Piero2, Tatiane T N Watanabe2, Umesh D Wankhade3, Kartik Shankar3, Chindo Hicks4, Martin J Ronis1.   

Abstract

Liver cancer results in a high degree of mortality, especially among men. As fatty liver disease is a risk factor for development of hepatocellular carcinoma, we investigated the role of dietary fat type in tumor promotion by high-fat diets in mice after initiation with the chemical carcinogen diethyl nitrosamine. Tumor incidence and multiplicity were significantly greater in males than those in females. In males, fat type had complex effects on tumorigenesis. Preneoplastic foci were most prevalent in mice fed a polyunsaturated fat diet enriched in docosahexaenoic acid, whereas carcinomas and large visible liver tumors were significantly greater in mice fed a saturated fat diet made with cocoa butter relative to mice fed mono- or polyunsaturated fats. Different mechanisms thus seemed involved in early and late tumor promotion. The hepatic transcriptome and gut microbiome were assessed for traits associated with tumorigenesis. Hepatic expression of more than 20% of all genes was affected by sex, whereas fat type affected fewer genes. In males, the saturated fat diet induced expression of the proto-oncogene Agap2 and affected the expression of several cytochrome P450 genes, and genes involved in lipid, bile acid and fatty acid metabolism. The gut microbiome had a higher level of genus Akkermansia and a lower level of Firmicutes in females than in males. Males fed saturated fat had an altered microbiome, including an enrichment of the genus Coprococcus. In conclusion, sex and the dietary fat type affect the gut microbiome, the hepatic transcriptome and ultimately hepatic tumor growth.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30325408      PMCID: PMC6487682          DOI: 10.1093/carcin/bgy141

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  45 in total

Review 1.   Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.

Authors:  G Seyda Seydel; Ozlem Kucukoglu; Akif Altinbasv; O Oguz Demir; Sezai Yilmaz; Hikmet Akkiz; Emrah Otan; Jan-Peter Sowa; Ali Canbay
Journal:  Ann Hepatol       Date:  2016 Sep-Oct       Impact factor: 2.400

2.  The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis.

Authors:  Robert M Bigsby; Andrea Caperell-Grant
Journal:  Carcinogenesis       Date:  2011-05-23       Impact factor: 4.944

3.  Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity.

Authors:  Tze Mun Loo; Fumitaka Kamachi; Yoshihiro Watanabe; Shin Yoshimoto; Hiroaki Kanda; Yuriko Arai; Yaeko Nakajima-Takagi; Atsushi Iwama; Tomoaki Koga; Yukihiko Sugimoto; Takayuki Ozawa; Masaru Nakamura; Miho Kumagai; Koichi Watashi; Makoto M Taketo; Tomohiro Aoki; Shuh Narumiya; Masanobu Oshima; Makoto Arita; Eiji Hara; Naoko Ohtani
Journal:  Cancer Discov       Date:  2017-02-15       Impact factor: 39.397

4.  Association between hepatitis C and hepatocellular carcinoma.

Authors:  Luis Jesuino de Oliveria Andrade; Argemiro D'Oliveira; Rosangela Carvalho Melo; Emmanuel Conrado De Souza; Carolina Alves Costa Silva; Raymundo Paraná
Journal:  J Glob Infect Dis       Date:  2009-01

Review 5.  The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Michael J Pagliassotti
Journal:  J Nutr Biochem       Date:  2008-04-21       Impact factor: 6.048

6.  Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice.

Authors:  Jin Li; Shaoqiang Lin; Paul M Vanhoutte; Connie W Woo; Aimin Xu
Journal:  Circulation       Date:  2016-04-25       Impact factor: 29.690

7.  Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease.

Authors:  Martin J J Ronis; January N Baumgardner; Neha Sharma; Jamie Vantrease; Matthew Ferguson; Yudong Tong; Xianli Wu; Mario A Cleves; Thomas M Badger
Journal:  Exp Biol Med (Maywood)       Date:  2013-02

8.  Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.

Authors:  Susan E Stanley; Dustin L Gable; Christa L Wagner; Thomas M Carlile; Vidya Sagar Hanumanthu; Joshua D Podlevsky; Sara E Khalil; Amy E DeZern; Maria F Rojas-Duran; Carolyn D Applegate; Jonathan K Alder; Erin M Parry; Wendy V Gilbert; Mary Armanios
Journal:  Sci Transl Med       Date:  2016-08-10       Impact factor: 17.956

9.  Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

Authors:  Robert J Wong; Ramsey Cheung; Aijaz Ahmed
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425

Review 10.  Adherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis.

Authors:  Lukas Schwingshackl; Carolina Schwedhelm; Cecilia Galbete; Georg Hoffmann
Journal:  Nutrients       Date:  2017-09-26       Impact factor: 5.717

View more
  7 in total

1.  How to Maintain a Healthy Gut Microbiome in Children with Cancer? Gut Microbiome Association with Diet in Children with Solid Tumors Postchemotherapy.

Authors:  Shuqi Zhou; Melissa Martin; Christie Powell; Kathryn S Sutton; Bradley George; Thomas Olson; Konstantinos T Konstantinidis; Deborah W Bruner; Jinbing Bai
Journal:  OMICS       Date:  2022-02-25

2.  Dietary ε-Polylysine Affects on Gut Microbiota and Plasma Metabolites Profiling in Mice.

Authors:  Xuelei Zhang; Baoyang Xu; Zhenping Hou; Chunlin Xie; Yaorong Niu; Qiuzhong Dai; Xianghua Yan; Duanqin Wu
Journal:  Front Nutr       Date:  2022-04-28

3.  A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.

Authors:  Robin D Tucker; Victor Ciofoaia; Sandeep Nadella; Martha D Gay; Hong Cao; Matthew Huber; Anita Safronenka; Narayan Shivapurkar; Bhaskar Kallakury; Annie J Kruger; Alexander H K Kroemer; Jill P Smith
Journal:  Dig Dis Sci       Date:  2019-07-11       Impact factor: 3.199

4.  MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.

Authors:  Yi Ding; Jie Yang; Yawen Ma; Tengteng Yao; Xingyu Chen; Shengfang Ge; Lihua Wang; Xianqun Fan
Journal:  J Exp Clin Cancer Res       Date:  2019-12-19

Review 5.  Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma.

Authors:  Veronica Zelli; Chiara Compagnoni; Roberta Capelli; Alessandra Corrente; Mauro Di Vito Nolfi; Francesca Zazzeroni; Edoardo Alesse; Alessandra Tessitore
Journal:  Front Oncol       Date:  2022-07-15       Impact factor: 5.738

6.  Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

Authors:  Martin J Ronis; Kelly E Mercer; Kartik Shankar; Casey Pulliam; Kim Pedersen; Magnus Ingelman-Sundberg; Simonetta Friso; Derrick Samuelson; Luis Del Valle; Chris Taylor; David A Welsh
Journal:  Chem Biol Interact       Date:  2020-05-14       Impact factor: 5.192

Review 7.  Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma.

Authors:  Wei Jia; Cynthia Rajani; Hongxi Xu; Xiaojiao Zheng
Journal:  Protein Cell       Date:  2020-08-14       Impact factor: 14.870

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.